Eigen Value ANalySis (EVANS) ‒ A Tool to Address Pharmacodynamic, Pharmacokinetic and Toxicity IssuesBlessy Joseph, Evans C. Coutinho, Anish Gomatam et al.|International Journal of Quantitative Structure-Property Relationships|2019Cited by 6
Flexibility of Important HIV-1 Targets and in silico Design of anti- HIV DrugsElvis A. F. Martis, Driss Cherqaoui, Ismail Hdoufane et al.|Current Chemical Biology|2017Cited by 2
<i>In silico</i>optimization of pharmacokinetic properties and receptor binding affinity simultaneously: a ‘parallel progression approach to drug design’ applied to β-blockersPoonam Advani, Evans C. Coutinho, Vijay M. Khedkar et al.|Journal of Biomolecular Structure and Dynamics|2015Cited by 1
<i>In silico</i> optimization of pharmacokinetic properties and receptor binding affinity simultaneously: a ‘parallel progression approach to drug design’ applied to β-blockersPoonam Advani, Evans C. Coutinho, Blessy Joseph et al.|Figshare|2016Cited by 0
<i>In silico</i> optimization of pharmacokinetic properties and receptor binding affinity simultaneously: a ‘parallel progression approach to drug design’ applied to β-blockersPoonam Advani, Evans C. Coutinho, Blessy Joseph et al.|INDIGO (University of Illinois at Chicago)|2016Cited by 0